We are live on ! Find out more
AIM

AIM ImmunoTech

14 hedge funds and large institutions have $2.57M invested in AIM ImmunoTech in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

8% more funds holding

Funds holding: 1314 (+1)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

48% less capital invested

Capital invested by funds: $4.91M → $2.57M (-$2.34M)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

AIM Hedge Fund Activity: Q4 2016 in Review

14 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2016, worth a combined $2.57M — down 48% from $4.91M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new AIM positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $52.4K. The largest seller was Anson Funds Management, cutting an estimated $222K.

  • 14 institutional investors held AIM ImmunoTech (AIM) as of Q4 2016, up from 13 in Q3 2016.
  • Funds reported $2.57M of AIM ImmunoTech stock for Q4 2016, down 48% quarter-over-quarter.
  • 2 funds opened new AIM ImmunoTech positions in Q4 2016 and 1 closed out, a net change of +1 holder.
  • The largest AIM ImmunoTech buyer in Q4 2016 was Susquehanna International Group, an estimated $52.4K added.
  • The largest AIM ImmunoTech seller in Q4 2016 was Anson Funds Management, an estimated $222K sold.

Based on aggregated 13F filings for Q4 2016.